Skip to content
healthcare.dev

Zenzedi

NDC 24338-850, Dextroamphetamine Sulfate, tablet, from Azurity Pharmaceuticals, Inc..

Product NDC
24338-850
Status
Listed
Labeler
Azurity Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090533
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/24338-850 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEXTROAMPHETAMINE SULFATE2.5 mg/1

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]

Package NDCNDC-11Package
24338-850-032433808500330 TABLET in 1 BOTTLE (24338-850-03)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d6394df5-f2c9-47eb-b57e-f3e9cfd94f84

Use it

Look up 24338-850 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/24338-850 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 24338-850. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.